AAAAAA

   
Results: 1-23 |
Results: 23

Authors: Melk, A Halloran, PF
Citation: A. Melk et Pf. Halloran, Cell senescence and its implications for nephrology, J AM S NEPH, 12(2), 2001, pp. 385-393

Authors: Halloran, PF Melk, A
Citation: Pf. Halloran et A. Melk, Tailoring therapy: Balancing toxicity and chronic allograft dysfunction, TRANSPLAN P, 33(3A), 2001, pp. 7S-10S

Authors: Halloran, PF Miller, LW Urmson, J Ramassar, V Zhu, LF Kneteman, NM Solez, K Afrouzian, M
Citation: Pf. Halloran et al., IFN-gamma alters the pathology of graft rejection: Protection from early necrosis, J IMMUNOL, 166(12), 2001, pp. 7072-7081

Authors: Halloran, PF Afrouzian, M Ramassar, V Urmson, J Zhu, LF Helms, LMH Solez, K Kneteman, NM
Citation: Pf. Halloran et al., Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis, AM J PATH, 158(1), 2001, pp. 215-226

Authors: Kung, L Halloran, PF
Citation: L. Kung et Pf. Halloran, Calcineurin-targeted inhibition of immune reactivity, IMMUNOL MED, 29, 2001, pp. 1-30

Authors: Melk, A Ramassar, V Helms, LMH Moore, R Rayner, D Solez, K Halloran, PF
Citation: A. Melk et al., Telomere shortening in kidneys with age, J AM S NEPH, 11(3), 2000, pp. 444-453

Authors: Prommool, S Jhangri, GS Cockfield, SM Halloran, PF
Citation: S. Prommool et al., Time dependency of factors affecting renal allograft survival, J AM S NEPH, 11(3), 2000, pp. 565-573

Authors: Takei, Y Sims, TN Urmson, J Halloran, PF
Citation: Y. Takei et al., Central role for interferon-gamma receptor in the regulation of renal MHC expression, J AM S NEPH, 11(2), 2000, pp. 250-261

Authors: Mele, TS Halloran, PF
Citation: Ts. Mele et Pf. Halloran, The use of mycophenolate mofetil in transplant recipients, IMMUNOPHARM, 47(2-3), 2000, pp. 215-245

Authors: Halloran, PF
Citation: Pf. Halloran, Sirolimus and ciclosporin for renal transplantation, LANCET, 356(9225), 2000, pp. 179-180

Authors: Ivanyi, S Fahmy, H Brown, H Szenohradszky, P Halloran, PF Solez, K
Citation: S. Ivanyi et al., Peritubular capillaries in chronic renal allograft rejection: A quantitative ultrastructural study, HUMAN PATH, 31(9), 2000, pp. 1129-1138

Authors: Kung, L Halloran, PF
Citation: L. Kung et Pf. Halloran, Immunophilins may limit calcineurin inhibition by cyclosporine and tacrolimus at high drug concentrations, TRANSPLANT, 70(2), 2000, pp. 327-335

Authors: Halloran, PF
Citation: Pf. Halloran, Immunosuppression in the post-adaptation period, TRANSPLANT, 70(1), 2000, pp. 3-5

Authors: Sims, TN Halloran, PF
Citation: Tn. Sims et Pf. Halloran, MHC class II regulation in vivo in the mouse kidney, MICROBES IN, 1(11), 1999, pp. 903-912

Authors: Halloran, PF Melk, A Barth, C
Citation: Pf. Halloran et al., Rethinking chronic allograft nephropathy: The concept of accelerated senescence, J AM S NEPH, 10(1), 1999, pp. 167-181

Authors: Monaco, AP Burke, JF Ferguson, RM Halloran, PF Kahan, BD Light, JA Matas, AJ Solez, K
Citation: Ap. Monaco et al., Current thinking on chronic renal allograft rejection: Issues, concerns, and recommendations from a 1997 roundtable discussion, AM J KIDNEY, 33(1), 1999, pp. 150-160

Authors: Racusen, LC Solez, K Colvin, RB Bonsib, SM Castro, MC Cavallo, T Croker, BP Demetris, AJ Drachenberg, CB Fogo, AB Furness, P Gaber, LW Gibson, IW Glotz, D Goldberg, JC Grande, J Halloran, PF Hansen, HE Hartley, B Hayry, PJ Hill, CM Hoffman, EO Hunsicker, LG Lindblad, AS Marcussen, N Mihatsch, MJ Nadasdy, T Nickerson, P Olsen, TS Papadimitriou, JC Randhawa, PS Rayner, DC Roberts, I Rose, S Rush, D Salinas-Madrigal, L Salomon, DR Sund, S Taskinen, E Trpkov, K Yamaguchi, Y
Citation: Lc. Racusen et al., The Banff 97 working classification of renal allograft pathology, KIDNEY INT, 55(2), 1999, pp. 713-723

Authors: Halloran, PF
Citation: Pf. Halloran, Risk factors in renal transplantation and implications for immunosuppressive therapy, TRANSPLAN P, 31(1-2), 1999, pp. 351-352

Authors: Halloran, PF
Citation: Pf. Halloran, T-cell activation pathways: A transplantation perspective, TRANSPLAN P, 31(1-2), 1999, pp. 769-771

Authors: Halloran, PF Helms, LMH Kung, L Noujaim, J
Citation: Pf. Halloran et al., The temporal profile of calcineurin inhibition by cyclosporine in vivo, TRANSPLANT, 68(9), 1999, pp. 1356-1361

Authors: Inman, B Halloran, B Melk, A Ramassar, V Halloran, PF
Citation: B. Inman et al., Microchimerism in sensitized renal patients, TRANSPLANT, 67(10), 1999, pp. 1381-1383

Authors: Parfrey, NA El-Sheikh, A Monckton, EA Cockfield, SM Halloran, PF Linetsky, E
Citation: Na. Parfrey et al., Interferon-gamma gene expression during acute graft-versus-host disease: Relationship to MHC induction and tissue injury, J PATHOLOGY, 189(1), 1999, pp. 99-104

Authors: Ding, B Price, RL Borg, TK Weinberg, EO Halloran, PF Lorell, BH
Citation: B. Ding et al., Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin, CIRCUL RES, 84(6), 1999, pp. 729-734
Risultati: 1-23 |